Health and Fitness Health and Fitness
Fri, February 10, 2012
Thu, February 9, 2012

Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results Teleconference and Webcast


Published on 2012-02-09 13:08:24 - Market Wire
  Print publication without navigation


Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results Teleconference... -- SAN FRANCISCO, Feb. 9, 2012 /PRNewswire/ --

Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results Teleconference and Webcast

[ ]

SAN FRANCISCO, Feb. 9, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: [ ONXX ]) today announced that it will host a webcast and teleconference with management to discuss fourth quarter and full year 2011 financial results, as well as provide a general business overview, on Wednesday, February 22, 2012, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).  Financial results for the fourth quarter and full year ended December 31, 2011 will be released after market closes on February 22, 2012.

Interested parties may access a live webcast of the teleconference on the company's website at:
[ http://www.onyx-pharm.com/investors/event-calendar ]

or by dialing 847-585-4405 and using the passcode 31754065#.  A replay of the presentation will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 31754065# approximately one hour after the teleconference concludes.  The replay will be available through March 7, 2012. 

About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.  The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at [ www.onyx-pharm.com ].

SOURCE Onyx Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.onyx-pharm.com ]

Contributing Sources